In today’s recent session, 1.86 million shares of the Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) have been traded, and its beta is 1.26. Most recently the company’s share price was $1.20, and it changed around $0.05 or 4.35% from the last close, which brings the market valuation of the company to $0.80M. BDRX at last check was trading at a discount to its 52-week high of $41.50, offering almost -3358.33% off that amount. The share price’s 52-week low was $1.11, which indicates that the recent value has risen by an impressive 7.5% since then. We note from Biodexa Pharmaceuticals Plc ADR’s average daily trading volume that its 10-day average is 6.65 million shares, with the 3-month average coming to 2.51 million.
Biodexa Pharmaceuticals Plc ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended BDRX as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.
Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) trade information
Instantly BDRX has been showing a green trend so far today with a performance of 4.35% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.9300 on recent trading dayincreased the stock’s daily price by 37.82%. The company’s shares are currently down -70.37% year-to-date, but still down -6.98% over the last five days. On the other hand, Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) is -22.58% down in the 30-day period. We can see from the shorts that 0.23 million shares have been sold at a short interest cover period of 0.2 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 83.98%.
BDRX Dividends
Biodexa Pharmaceuticals Plc ADR’s next quarterly earnings report is expected to be released in June.
Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 2.30% of Biodexa Pharmaceuticals Plc ADR shares, and 8.34% of them are in the hands of institutional investors. The stock currently has a share float of 8.54%.
The former held 78.0 shares worth $92.0, making up 0.00% of all outstanding shares.
